- α-Isosafrole
- cis-3,4-Methylenedioxyphenylprop-1-ene
- cis-Isosafrole
- 5-[(1Z)-Prop-1-en-1-yl]-2H-1,3-benzodioxole
- 5-[(1Z)-Prop-1-en-1-yl]-1,3-benzodioxole
Dal Cason, TA. An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs J. Forensic Sci., 1 May 1990, 35 (3), 675–697. 2.2 MB. https://doi.org/10.1520/JFS12874J
Shulgin, AT. The separation and identification of the components of the aromatic ether fraction of essential oils by gas-liquid chromatography J. Chromatogr. A, 1 Jan 1967, 30, 54–61. 769 kB. https://doi.org/10.1016/S0021-9673(00)84112-6 #IVb GC
Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Hoffer, A; Osmond, H. The Hallucinogens, Academic Press, New York, . 3.9 MB. #Safrole
Sorokin, V; Beljaev, A; Ponkratov, K. Expert examination of MDA JCLIC, 1 Jul 1993, 3 (3), 13-15. 556 kB. IR